Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative

BMC Pediatrics

Volumn 12, Issue , 2012, Pages

  Savino, Francesco ^a   Viola, Serena ^a   Erasmo, Maiullari ^b   Di Nardo, Giovanni ^c   Oliva, Salvatore ^c   Cucchiara, Salvatore ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Children; Constipation; Laxatives; Macrogol; Polyethylene glycol

Indexed keywords

LAXATIVE; MACROGOL; MACROGOL 3350; ONLIGOL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC CONSTIPATION; CHRONIC DISEASE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FECES; FECES IMPACTION; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TASTE; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONSTIPATION; DOUBLE-BLIND METHOD; ELECTROLYTES; FECAL IMPACTION; FEMALE; HUMANS; LAXATIVES; MALE; POLYETHYLENE GLYCOLS;

EID: 84868675786     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-12-178     Document Type: Article

References (28)

1. Van Den Berg M, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol 2006, 101(10):2401-2409. 10.1111/j.1572-0241.2006.00771.x, 17032205.
2. Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006, 43(3):e1-e13. 10.1097/01.mpg.0000233159.97667.c3, 16954945, Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
3. Rubin G, Dale A. Chronic constipation in children. BMJ 2006, 333(7577):1051-1055. 10.1136/bmj.39007.760174.47, 1647395, 17110723.
4. Benninga MA, Voskuijl WP, Taminiau JA. Childhood constipation: Is there new light in the tunnel?. J Pediatr Gastroenterol Nutr 2004, 39:448-464. 10.1097/00005176-200411000-00002, 15572881.
5. Di Palma JA, Cleveland MV, McGowan J, Herrera JL. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol 2007, 102(9):1964-1971. 10.1111/j.1572-0241.2007.01365.x, 17573794.
6. DiPalma JA, Cleveland MB, McGowan J, Herrera JL. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J 2007, 100(11):1085-1090. 10.1097/SMJ.0b013e318157ec8f, 17984738.
7. Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001, 139:428-432. 10.1067/mpd.2001.117002, 11562624.
8. Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002, 34:372-377. 10.1097/00005176-200204000-00011, 11930092.
9. Youssef NN, Peters JM, Henderson W, et al. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 2002, 141:410-414. 10.1067/mpd.2002.126603, 12219064.
10. Bekkali NL, van den Berg MM, Dijkgraaf MG, van Wijk MP, Bongers ME, Liem O, Benninga MA. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics 2009, 124(6):e1108-e1115. 10.1542/peds.2009-0022, 19948614.
11. Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 2010, 7:CD007570.
12. De Giorgio R, Cestari R, Corinaldesi R, et al. Use of macrogol 4000 in chronic constipation. Eur Rev Med Pharmacol Sci 2011, 15(8):960-966.
13. Thomson MA, Jenkins HR, Bisset WM, et al. Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study. Arch Dis Child 2007, 92(11):996-1000. 10.1136/adc.2006.115493, 2083581, 17626140.
14. Hardikar W, Cranswick N, Heine RG. Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study. J Paediatr Child Health 2007, 43(7-8):527-531.
15. Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P, Mastropaolo G, Lucà MG, Galeazzi R, Peruzzi E. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000, 46(4):522-526. 10.1136/gut.46.4.522, 1727881, 10716682.
16. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004, 53(11):1590-1594. 10.1136/gut.2004.043620, 1774276, 15479678.
17. Nurko S, Youssef NN, Sabri M, Langseder A, McGowan J, Cleveland M, Di Lorenzo C. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr 2008, 153(2):254-261. 10.1016/j.jpeds.2008.01.039, 18534221.
18. Dupont C, Leluyer B, Maamri N, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005, 41:625-633. 10.1097/01.mpg.0000181188.01887.78, 16254521.
19. Dupont C, Leluyer B, Amar F, Kalach N, Benhamou PH, Mouterde O, Vannerom PY. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr 2006, 42(2):178-185. 10.1097/01.mpg.0000189349.17549.a9, 16456412.
20. Maiullari E, Bianco ER, Cortese MG, et al. Conservative treatment of children constipation with Macrogol 4000. Minerva Pediatr 2008, 60(4):407-410.
21. Szojda MM, Mulder CJ, Felt-Bersma RJ. Differences in taste between two polyethylene glycol preparations. J Gastrointestin Liver Dis 2007, 16(4):379-381.
22. Pashankar DS, Loening-Baucke V, Bishop WP. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med 2003, 157(7):661-664. 10.1001/archpedi.157.7.661, 12860787.
23. Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child 2009, 94(2):156-160. 2614562, 19019885.
24. Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics 2006, 118(2):528-535. 10.1542/peds.2006-0220, 16882804.
25. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Inhibition of water and electrolyte absorption by polyethylene glycol (PEG). Gastroenterology 1980, 79(1):35-39.
26. Loening-Baucke V, Krishna R, Pashankar DS. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 2004, 39(5):536-539. 10.1097/00005176-200411000-00016, 15572895.
27. Michail S, Gendy E, Preud'Homme D, et al. Polyethylene glycol for constipation in children younger than eighteen months old. J Pediatr Gastroenterol Nutr 2004, 39(2):197-199. 10.1097/00005176-200408000-00014, 15269628.
28. Pashankar DS, Bishop WP, Loening-Baucke V. Long-term efficacy of polyethylene glycol 3350 for the treatment of chronic constipation in children with and without encopresis. Clin Pediatr (Phila) 2003, 42(9):815-819.